Symposia: Emerging Tools, Techniques, and Artificial Intelligence in Hematology
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Bleeding and Clotting, Artificial intelligence (AI), Acquired Marrow Failure Syndromes, Sickle Cell Disease, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, AML, MDS, Fundamental Science, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bone Marrow Failure Syndromes, Lymphomas, CLL, Non-Hodgkin lymphoma, Drug development, APL, MPN, Translational Research, Epidemiology, Assays, Elderly, Genomics, Bioinformatics, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Plasma Cell Disorders, B Cell lymphoma, Clinical Research, Hemoglobinopathies, Hematopoiesis, Blood banking, Chronic Myeloid Malignancies, CMML, Diseases, Immune mechanism, Treatment Considerations, Biological therapies, Immunology, Real-world evidence, Adverse Events, Lymphoid Malignancies, Computational biology, Biological Processes, Myeloid Malignancies, Emerging technologies, Technology and Procedures, Molecular biology, Study Population, Multi-systemic interactions, Profiling, Human, Pathogenesis, Imaging, Measurable Residual Disease , Machine learning, Molecular testing, Natural language processing, Omics technologies, Pathology
Type: Poster
Hematology Disease Topics & Pathways:
Research, Bleeding and Clotting, Artificial intelligence (AI), Acquired Marrow Failure Syndromes, Sickle Cell Disease, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, AML, MDS, Fundamental Science, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bone Marrow Failure Syndromes, Lymphomas, CLL, Non-Hodgkin lymphoma, Drug development, APL, MPN, Translational Research, Epidemiology, Assays, Elderly, Genomics, Bioinformatics, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Plasma Cell Disorders, B Cell lymphoma, Clinical Research, Hemoglobinopathies, Hematopoiesis, Blood banking, Chronic Myeloid Malignancies, CMML, Diseases, Immune mechanism, Treatment Considerations, Biological therapies, Immunology, Real-world evidence, Adverse Events, Lymphoid Malignancies, Computational biology, Biological Processes, Myeloid Malignancies, Emerging technologies, Technology and Procedures, Molecular biology, Study Population, Multi-systemic interactions, Profiling, Human, Pathogenesis, Imaging, Measurable Residual Disease , Machine learning, Molecular testing, Natural language processing, Omics technologies, Pathology
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH